Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Daiichi Sankyo
Chubb
Covington
Moodys
Colorcon
Citi
Harvard Business School
Chinese Patent Office
QuintilesIMS

Generated: January 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020648

« Back to Dashboard

NDA 020648 describes DIASTAT ACUDIAL, which is a drug marketed by Valeant Pharms North and is included in one NDA. It is available from three suppliers. Additional details are available on the DIASTAT ACUDIAL profile page.

The generic ingredient in DIASTAT ACUDIAL is diazepam. There are eight drug master file entries for this compound. Fifty-two suppliers are listed for this compound. Additional details are available on the diazepam profile page.
Summary for 020648
Tradename:DIASTAT ACUDIAL
Applicant:Valeant Pharms North
Ingredient:diazepam
Patents:0
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 020648
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DIASTAT diazepam GEL;RECTAL 020648 NDA AUTHORIZED GENERIC Teva Pharmaceuticals USA Inc 0093-6137 0093-6137-32 2 SYRINGE, PLASTIC in 1 PACKAGE (0093-6137-32) > .5 mL in 1 SYRINGE, PLASTIC
DIASTAT diazepam GEL;RECTAL 020648 NDA AUTHORIZED GENERIC Teva Pharmaceuticals USA Inc 0093-6138 0093-6138-32 2 SYRINGE, PLASTIC in 1 PACKAGE (0093-6138-32) > 2 mL in 1 SYRINGE, PLASTIC

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:GEL;RECTALStrength2.5MG/0.5ML (5MG/ML)
Approval Date:Jul 29, 1997TE:RLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:GEL;RECTALStrength5MG/ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Jul 29, 1997TE:RLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:GEL;RECTALStrength10MG/2ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Jul 29, 1997TE:RLD:Yes

Expired US Patents for NDA 020648

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Valeant Pharms North DIASTAT diazepam GEL;RECTAL 020648-001 Jul 29, 1997 ➤ Subscribe ➤ Subscribe
Valeant Pharms North DIASTAT ACUDIAL diazepam GEL;RECTAL 020648-006 Sep 15, 2005 ➤ Subscribe ➤ Subscribe
Valeant Pharms North DIASTAT diazepam GEL;RECTAL 020648-005 Jul 29, 1997 ➤ Subscribe ➤ Subscribe
Valeant Pharms North DIASTAT ACUDIAL diazepam GEL;RECTAL 020648-007 Sep 15, 2005 ➤ Subscribe ➤ Subscribe
Valeant Pharms North DIASTAT diazepam GEL;RECTAL 020648-002 Jul 29, 1997 ➤ Subscribe ➤ Subscribe
Valeant Pharms North DIASTAT diazepam GEL;RECTAL 020648-003 Jul 29, 1997 ➤ Subscribe ➤ Subscribe
Valeant Pharms North DIASTAT diazepam GEL;RECTAL 020648-004 Jul 29, 1997 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Fish and Richardson
Merck
QuintilesIMS
Chubb
Boehringer Ingelheim
UBS
Johnson and Johnson
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot